Re: Feeling cautiously optimistic about PGEN's upcoming data readout
I often disagree with the massive enthusiasm 2050 has especially when it says the company is an existential threat to Bristol Myers and prior to that Celgene. That said with the two phase ones open label they should have some idea internally. The comments from the company that they are on schedule and looking forward data to me is also encouraging. What Helen has accomplished having three clinical trials in her brief time as leader of the firm is indeed impressive. Now what is needed is positive data and I agree with 2050 it feels like we will get some. So Iím sending positive molecules their way!
I look for data this quarter knowing they said second half..
Then hope she has ready her plan to go forward..
As I have mentioned several times before after meeting her several times I come away thinking she is one of the most organized people I know. When she sets a goal she has every intention of meeting it..she is serious and focused..
We know she has had clinical success before and now we hope she can catch lightening one more time!